{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Adhesion molecules", "Complement", "Human microvascular endothelial cells (HMEC)", "Inflammatory cytokines", "Nuclear factor-kappa B (NF-\u03baB)"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36411899", "DateRevised": {"Year": "2022", "Month": "11", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "14"}], "Language": ["eng"], "ELocationID": ["e11622", "10.1016/j.heliyon.2022.e11622"], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "8", "Issue": "11", "PubDate": {"Year": "2022", "Month": "Nov"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "Acteoside attenuates acute lung injury following administration of cobra venom factor to mice.", "Pagination": {"StartPage": "e11622", "MedlinePgn": "e11622"}, "Abstract": {"AbstractText": ["Acteoside, a water-soluble active constituent of diverse valuable medicinal vegetation, has shown strong anti-inflammatory property. However, studies on the anti-inflammatory property of acteoside in complement-induced acute lung injury (ALI) are limited. Therefore, this study aims to evaluate the anti-inflammatory activity of acteoside in cobra venom factor (CVF)-stimulated human microvascular endothelial cells (HMEC) and in ALI mice model.", "In this study, we investigated the effects of acteoside (20, 10, and 5 \u03bcg/mL) <i>in vitro</i> in CVF induced HMECs and the activity of acteoside (100, 50, and 20 mg/kg/day bodyweight) <i>in vivo</i> in CVF induced ALI mice. Each eight male mice were orally administered acteoside or the positive drug PDTC (100 mg/kg/day) for 7 days before CVF (35 \u03bcg/kg) injection. After injection for 1 h, the pharmacological effects of acteoside were investigated by spectrophotometry, pathological examination, enzyme-linked immunosorbent assay, and immunohistochemistry.", "<i>In vitro</i>, acteoside (20, 10, and 5 \u03bcg/mL) reduced the protein expression of adhesion molecules and pro-inflammatory cytokines and transcriptional activity of NF-\u03baB (<i>P</i> < 0.01). <i>In vivo</i> studies showed that acteoside dose-dependently alleviated lung histopathologic lesion, inhibited the production of the protein content of BALF, leukocyte cell number, lung MPO activity, and expression levels of IL-6, TNF-\u03b1, and ICAM-1, and suppressed the C5b-9 deposition and NF-\u03baB activation in CVF-induced acute lung inflammation in mice (<i>P</i> < 0.05, 0.01).", "This study demonstrates that acteoside exerts strong anti-inflammatory activities in the CVF-induced acute lung inflammation model and suggests that acteoside is a potential therapeutic agent for complement-related inflammatory diseases."], "CopyrightInformation": "\u00a9 2022 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Karst Science, Guizhou Normal University/State Engineering Technology Institute for Karst Desertification Control, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products, Guizhou Province and Chinese Academy of Sciences, Guiyang, China."}, {"Identifier": [], "Affiliation": "Mordern Research Center for Traditional Chinese Medicine, Institute of Molecular Science, Shanxi University, Taiyuan 030006, China."}], "LastName": "Guo", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Karst Science, Guizhou Normal University/State Engineering Technology Institute for Karst Desertification Control, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products, Guizhou Province and Chinese Academy of Sciences, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guyuan No. 8 Middle School, Guyuan, China."}], "LastName": "Liu", "ForeName": "Qiao-Zhou", "Initials": "QZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Karst Science, Guizhou Normal University/State Engineering Technology Institute for Karst Desertification Control, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products, Guizhou Province and Chinese Academy of Sciences, Guiyang, China."}], "LastName": "Zhu", "ForeName": "Fang-Juan", "Initials": "FJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "General Ward, Guizhou Provincial People's Hospital, Guiyang, China."}], "LastName": "Li", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products, Guizhou Province and Chinese Academy of Sciences, Guiyang, China."}], "LastName": "Li", "ForeName": "Jiao", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products, Guizhou Province and Chinese Academy of Sciences, Guiyang, China."}], "LastName": "Guo", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products, Guizhou Province and Chinese Academy of Sciences, Guiyang, China."}], "LastName": "Sun", "ForeName": "Qian-Yun", "Initials": "QY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Karst Science, Guizhou Normal University/State Engineering Technology Institute for Karst Desertification Control, Guiyang, China."}], "LastName": "Yang", "ForeName": "Qing-Xiong", "Initials": "QX"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wang J., Ma C.H., Wang S.M. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-kappaB pathway in vivo and in vitro. Toxicol. Appl. Pharmacol. 2015;285(2):128\u2013135.", "ArticleIdList": ["25902336"]}, {"Citation": "Matthay M.A., Zimmerman G.A. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am. J. Respir. Cell Mol. Biol. 2005;33(4):319\u2013327.", "ArticleIdList": ["PMC2715340", "16172252"]}, {"Citation": "Salton F., Confalonieri P., Campisciano G., et al. Cytokine profiles as potential prognostic and therapeutic markers in SARS-CoV-2-induced ARDS. J.\u00a0Clin. Med. 2022;11(11):2951.", "ArticleIdList": ["PMC9180983", "35683340"]}, {"Citation": "Wilson J.G., Simpson L.J., Ferreira A.M., et al. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight. 2020;5(17)", "ArticleIdList": ["PMC7526438", "32706339"]}, {"Citation": "Robbins R.A., Russ W.D., Rasmussen J.K., Clayton M.M. Activation of the complement system in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1987;135(3):651\u2013658.", "ArticleIdList": ["3826891"]}, {"Citation": "Pandya P.H., Wilkes D.S. Complement system in lung disease. Am. J. Respir. Cell Mol. Biol. 2014;51(4):467\u2013473.", "ArticleIdList": ["PMC4189484", "24901241"]}, {"Citation": "Dunkelberger J.R., Song W.C. Complement and its role in innate and adaptive immune responses. Cell Res. 2010;20(1):34\u201350.", "ArticleIdList": ["20010915"]}, {"Citation": "Holers V.M. The complement system as a therapeutic target in autoimmunity. Clin. Immunol. 2003;107(3):140\u2013151.", "ArticleIdList": ["12804527"]}, {"Citation": "Thurman J.M., Holers V.M. The central role of the alternative complement pathway in human disease. J.\u00a0Immunol. 2006;176(3):1305\u20131310.", "ArticleIdList": ["16424154"]}, {"Citation": "Mowery N.T., Terzian W.T.H., Nelson A.C. Acute lung injury. Curr. Probl. Surg. 2020;57(5):100777.", "ArticleIdList": ["32505224"]}, {"Citation": "Bosmann M., Ward P.A. Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis. Adv. Exp. Med. Biol. 2012;946:147\u2013159.", "ArticleIdList": ["PMC3372066", "21948367"]}, {"Citation": "Vogel C.W., Fritzinger D.C. Cobra venom factor: structure, function, and humanization for therapeutic complement depletion. Toxicon. 2010;56(7):1198\u20131222.", "ArticleIdList": ["20417224"]}, {"Citation": "Guo J., Li M., Yang Y., et al. Pretreatment with atorvastatin ameliorates cobra venom factor-induced acute lung inflammation in mice. BMC Pulm. Med. 2020;20(1):263.", "ArticleIdList": ["PMC7552367", "33046059"]}, {"Citation": "Hagio T., Nakao S., Matsuoka H., et al. Inhibition of neutrophil elastase activity attenuates complement-mediated lung injury in the hamster. Eur. J. Pharmacol. 2001;426(1-2):131\u2013138.", "ArticleIdList": ["11525781"]}, {"Citation": "Till G.O., Johnson K.J., Kunkel R., Ward P.A. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J.\u00a0Clin. Invest. 1982;69(5):1126\u20131135.", "ArticleIdList": ["PMC370177", "7068850"]}, {"Citation": "Till G.O., Ward P.A. Systemic complement activation and acute lung injury. Fed. Proc. 1986;45(1):13\u201318.", "ArticleIdList": ["3940902"]}, {"Citation": "He J., Hu X.P., Zeng Y., et al. Advanced research on acteoside for chemistry and bioactivities. J.\u00a0Asian Nat. Prod. Res. 2011;13(5):449\u2013464.", "ArticleIdList": ["21534045"]}, {"Citation": "Wu X., He W., Zhang H., et al. Acteoside: a lipase inhibitor from the Chinese tea Ligustrum purpurascens kudingcha. Food Chem. 2014;142:306\u2013310.", "ArticleIdList": ["24001846"]}, {"Citation": "Alipieva K., Korkina L., Orhan I.E., Georgiev M.I. Verbascoside--a review of its occurrence, (bio)synthesis and pharmacological significance. Biotechnol. Adv. 2014;32(6):1065\u20131076.", "ArticleIdList": ["25048704"]}, {"Citation": "Sun Q.Y., Chen G., Guo H., et al. Prolonged cardiac xenograft survival in Guinea pig-to-rat model by a highly active cobra venom factor. Toxicon. 2003;42(3):257\u2013262.", "ArticleIdList": ["14559076"]}, {"Citation": "Ye Q.L., Sun Q.Y., Li M. Inflammatory mediators releasing and apoptosis of endothelial cell induced by cobra venom metalloproteinase atrase A (in Chinese) Chin. Pharmacol. Bull. 2009;25(8):1001\u20131006."}, {"Citation": "Li J., Guo J., Li M., Sun Q.Y. Intervention effect of tetramethylpyrazine on inflammatory response of endothelial cells induced by activated complement alternative pathway (in Chinese) Chin. Pharmacol. Bull. 2019;35(1):90\u201395."}, {"Citation": "Proctor L.M., Strachan A.J., Woodruff T.M., et al. Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats. Int. Immunopharm. 2006;6(8):1224\u20131232.", "ArticleIdList": ["16782534"]}, {"Citation": "Goldblum S.E., Wu K.M., Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J.\u00a0Appl. Physiol. 1985;59(6):1978\u20131985.", "ArticleIdList": ["3001018"]}, {"Citation": "Schingnitz U., Hartmann K., Macmanus C.F., et al. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J.\u00a0Immunol. 2010;184(9):5271\u20135279.", "ArticleIdList": ["PMC2858788", "20348420"]}, {"Citation": "Kilgore K.S., Shen J.P., Miller B.F., et al. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J.\u00a0Immunol. 1995;155(3):1434\u20131441.", "ArticleIdList": ["7543521"]}, {"Citation": "Lozada C., Levin R.I., Huie M., et al. Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc. Natl. Acad. Sci. U. S. A. 1995;92(18):8378\u20138382.", "ArticleIdList": ["PMC41160", "7545301"]}, {"Citation": "Ward P.A. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann. N. Y. Acad. Sci. 1996;796:104\u2013112.", "ArticleIdList": ["8906217"]}, {"Citation": "Sun Q.Y., Li M., Ye Q.L., Li H.L. Endothelial cell activation and injury induced by complement alternative pathway (in Chinese) Chin. Pharma. Bull. 2012;28(7):925\u2013929."}, {"Citation": "Rahman A., Fazal F. Blocking NF-\u03baB: an inflammatory issue. Proc. Am. Thorac. Soc. 2011;8(6):497\u2013503.", "ArticleIdList": ["PMC3359076", "22052926"]}, {"Citation": "Liaudet L., Pacher P., Mabley J.G., et al. Activation of poly (ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am. J. Respir. Crit. Care Med. 2002;165(3):372\u2013377.", "ArticleIdList": ["11818323"]}, {"Citation": "Zhang Z., Luo Z., Bi A., et al. Compound edaravone alleviates lipopolysaccharide (LPS)-induced acute lung injury in mice. Eur. J. Pharmacol. 2017;811:1\u201311.", "ArticleIdList": ["28552343"]}, {"Citation": "Schmid E., Warner R.L., Crouch L.D., et al. Neutrophil chemotactic activity and C5a following systemic activation of complement in rats. Inflammation. 1997;21(3):325\u2013333.", "ArticleIdList": ["9246574"]}, {"Citation": "Bolger M.S., Ross D.S., Jiang H., et al. Complement levels and activity in the normal and LPS-injured lung. Am. J. Physiol. Lung Cell Mol. Physiol. 2007;292(3):L748\u2013759.", "ArticleIdList": ["17071722"]}, {"Citation": "Markiewski M.M., Lambris J.D. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 2007;171(3):715\u2013727.", "ArticleIdList": ["PMC1959484", "17640961"]}, {"Citation": "McClintock S.D., Hoesel L.M., Das S.K., et al. Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J.\u00a0Appl. Toxicol. 2006;26(2):126\u2013131.", "ArticleIdList": ["16252256"]}, {"Citation": "Sun S.H., Wang H.B., Zhao G.Y., et al. A\u00a0role for complement in paraquat-induced acute lung injury. Mol. Immunol. 2010;47(13):2212\u20132213."}, {"Citation": "Wang R., Xiao H., Guo R., et al. The role of C5a in acute lung injury induced by highly pathogenic viral infections. Emerg. Microb. Infect. 2015;4(5):e28.", "ArticleIdList": ["PMC4451266", "26060601"]}, {"Citation": "Wu X., Yao D., Bao L., et al. Ficolin A derived from local macrophages and neutrophils protects against lipopolysaccharide-induced acute lung injury by activating complement. Immunol. Cell Biol. 2020;98(7):595\u2013606.", "ArticleIdList": ["32339310"]}, {"Citation": "Zambelli V., Rizzi L., Delvecchio P., et al. JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice. Pulm. Pharmacol. Ther. 2020;62", "ArticleIdList": ["32205280"]}, {"Citation": "Till G.O., Morganroth M.L., Kunkel R., Ward P.A. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat. Am. J. Pathol. 1987;129(1):44\u201353.", "ArticleIdList": ["PMC1899690", "3661679"]}, {"Citation": "Acosta J., Qin X., Halperin J. Complement and complement regulatory proteins as potential molecular targets for vascular diseases. Curr. Pharmaceut. Des. 2004;10(2):203\u2013211.", "ArticleIdList": ["14754399"]}, {"Citation": "Langeggen H., Pausa M., Johnson E., et al. The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system. Clin. Exp. Immunol. 2000;121(1):69\u201376.", "ArticleIdList": ["PMC1905676", "10886241"]}, {"Citation": "Karpman D., Stahl A.L., Arvidsson I., et al. Complement interactions with blood cells, endothelial cells and microvesicles in thrombotic and inflammatory conditions. Adv. Exp. Med. Biol. 2015;865:19\u201342.", "ArticleIdList": ["26306441"]}, {"Citation": "Zoja C., Buelli S., Morigi M. Shiga toxin triggers endothelial and podocyte injury: the role of complement activation. Pediatr. Nephrol. 2019;34(3):379\u2013388.", "ArticleIdList": ["29214442"]}, {"Citation": "Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999;18(49):6853\u20136866.", "ArticleIdList": ["10602461"]}, {"Citation": "Zhao X., Zhao B., Zhao Y., et al. Protective effect of anisodamine on bleomycin-induced acute lung injury in immature rats via modulating oxidative stress, inflammation, and cell apoptosis by inhibiting the JAK2/STAT3 pathway. Ann. Transl. Med. 2021;9(10):859.", "ArticleIdList": ["PMC8184412", "34164493"]}, {"Citation": "Cao F., Tian X., Li Z., et al. Suppression of NLRP3 inflammasome by erythropoietin via the EPOR/JAK2/STAT3 pathway contributes to attenuation of acute lung injury in mice. Front. Pharmacol. 2020;11:306.", "ArticleIdList": ["PMC7096553", "32265704"]}, {"Citation": "Li H.L., Sun Q.Y., Li M., Shi J.S. Activation of NF-\u03baB, p38MAPK, and JAK2 in endothelial cells induced by activated complement alternative pathway and intervention by inhibitors (in Chinese), Chin. J.\u00a0Cell Biol. 2013;35(6):836\u2013841."}, {"Citation": "Li C.S., Sun Q.Y. Effect of three chemical molecules on adhesion molecules expression in HMECs induced by activated complement alternative pathway (in Chinese) Chin. Pharmacol. Bull. 2015;31(10):1421\u20131426."}, {"Citation": "Qiao Z., Tang J., Wu W., et al. Acteoside inhibits inflammatory response via JAK/STAT signaling pathway in osteoarthritic rats. BMC Compl. Alternative Med. 2019;19(1):264.", "ArticleIdList": ["PMC6781407", "31590658"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "11"}, {"Year": "2022", "Month": "8", "Day": "17"}, {"Year": "2022", "Month": "11", "Day": "7"}, {"Year": "2022", "Month": "11", "Day": "22", "Hour": "1", "Minute": "49"}, {"Year": "2022", "Month": "11", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "11", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["36411899", "PMC9674544", "10.1016/j.heliyon.2022.e11622", "S2405-8440(22)02910-3"]}}], "PubmedBookArticle": []}